If you need more lookups,
subscriptions start at $34 USD/month.
Rene Alvarez Location
San Francisco, CA, US
Rene Alvarez Work
Head of Regulatory and Scientific Writing @ (March 2023 - Present)
Senior Director Medical Writing @ (February 2022 - February 2023)
Senior Director, Medical Writing @ (July 2020 - February 2022)
Director, Medical Writing @ (January 2019 - July 2020)
Director, Medical Writing @ (October 2016 - October 2018)
Head of Medical Writing @ (October 2013 - October 2016)
Senior Manager, Medical Writing @ (April 2012 - August 2013)
Senior Medical Writer @ (April 2011 - April 2012)
Manager of Regulatory Writing @ (January 2009 - May 2011)
Medical Writer @ (November 2006 - January 2009)
Senior Medical Writer @ (November 2006 - December 2007)
Senior Medical Writer and Associate Writer @ ProEd Communications (February 2005 - October 2005)
Medical Writer @ (March 2004 - April 2005)
Rene Alvarez Education
UT Health San Antonio
(Microbiology)
1997-2003
University of the Incarnate Word
MA (Epidemiology/Biology)
1994-1996
Texas A&M University-Kingsville
BS (Biology)
1990-1994
Rene Alvarez Skills
Medical Writing
Oncology
Clinical Trials
IND
Therapeutic Areas
CTMS
Pharmaceutical Industry
Regulatory Affairs
Protocol
Immunology
Clinical Development
Regulatory Submissions
Biotechnology
FDA
Clinical Research
Medicine
Drug Development
Infectious Diseases
GCP
CRO
EDC
CRO Management
Medical Affairs
Pharmacovigilance
Project Management
Research
Social Media
Writing
Customer Service
Rene Alvarez Summary
Rene Alvarez, based in San Francisco, CA, US, is currently a Head of Regulatory and Scientific Writing at SystImmune. Rene Alvarez brings experience from previous roles at Acepodia, Catalyst Biosciences and Sunesis Pharmaceuticals, Inc.. Rene Alvarez holds a 1997 - 2003 UT Health San Antonio. With a robust skill set that includes Medical Writing, Oncology, Clinical Trials, IND, Therapeutic Areas and more. Rene Alvarez has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Rene Alvarez?
Find contact details for 700 million professionals.